Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Abbott LaboratoriesABT35.734.885.0220.3914.74%6.11%58.41$115.03$187.78184,790$114.13

Detail of Abbott Laboratories

 
CEO
Mr. Robert B. Ford
Employees
114000
Industry
Medical Devices
Sector
Healthcare
Market cap
$199B

Company details

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$40.72B
Cost of goods (CoG)
-$18.23B
Gross profit (GP)
$22.50B
Operating expense (OE)
-$14.10B
Research and development (R&D)
-$2.75B
General and administrative (G&A)
-$11.34B
Operating income (OI)
$6.48B
Other income expense (OIE)
-$285.00M
Pretax income (PI)
$6.51B
Tax (TAX)
-$952.00M
Net income (NI)
$5.56B
Abbott Laboratories
ABT • XNYS • US
$114.13
+21.07 (22.66%)
Stock vs Industry average
  • Industry average

Dividend yield
1.93%
Trailing annual dividend rate
$2.20
Payout ratio
65.65%
EPS
$3.19
Margin profit
13.99%
52 week low
$93.589996
52 week high
$120.959999
50-day simple moving average
$115.63
200-day simple moving average
$115.03
Percent held by insiders
0.52%
Percent held by institutions
79.57%
Dividend yield
1.84%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ABT +20.67%
eps change
ABT -5.54%